Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
T-62 in Postherpetic Neuralgia
NCT00506610Phase 2Withdrawn
- Sponsor
- Pfizer
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in postherpetic neuralgia (PHN) comparing T-62 with Placebo (2 arms). Primary endpoints: Pain Intensity Difference scores, Various pain related assessment and 2 more. Status: withdrawn.
02
Drugs
T-62
03
Conditions
postherpetic neuralgia (PHN)
Beyond the preview
Go deeper on NCT00506610.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00506610.